114:
296:
184:
22:
63:
475:
for tumor growth inhibition and for vaccines in treating cancer and infected diseases. He has authored or co-authored more than 600 papers with an H-index of 137. He is also the inventor or co-inventor of 22 US and foreign patents. In 2004, he received the
596:
484:. He was named a Highly Cited Researcher in “Pharmacology & Toxicology” and then in “Cross Field” each year since 2016. Huang has also co-founded 6 biotech start-ups in the past.
480:, which is the highest honor in liposome research. He was the recipient of the 2013 Distinguished Pharmaceutical Scientist Award which is the highest scientific recognition of the
147:
537:
581:
404:
263:
606:
601:
591:
576:
586:
304:
501:
386:
242:
224:
165:
49:
566:
532:
400:
267:
259:
202:
133:
367:
571:
561:
339:
408:
35:
320:
346:
541:
309:
143:
353:
313:
194:
129:
124:
556:
416:
271:
335:
423:
non-viral vector and has designed and manufactured the cationic lipid vector for the first non-viral
428:
73:
528:
481:
88:
206:
41:
360:
505:
424:
84:
550:
440:
197:
or has been extensively edited by the subject or by someone connected to the subject
477:
436:
412:
275:
113:
323:. Contentious material about living people that is unsourced or poorly sourced
432:
420:
472:
468:
279:
452:
464:
448:
444:
460:
456:
289:
177:
107:
56:
15:
399:
Huang is the Fred
Eshelman Distinguished Professor, in the
427:
in 1992. He was also the first to publish the activity of
139:
80:
274:
department. He has authored and co-authored over 570
597:
University of North
Carolina at Chapel Hill faculty
258:is a Fred Eshelman Distinguished Professor in the
482:American Association of Pharmaceutical Scientists
205:policy. There may be relevant discussion on the
128:, potentially preventing the article from being
451:. He also continues research in establishing a
201:It may need editing to conform to Knowledge's
8:
431:(PEG) in prolonging the circulation time of
411:. Huang’s research has been in the area of
50:Learn how and when to remove these messages
148:reliable, independent, third-party sources
387:Learn how and when to remove this message
243:Learn how and when to remove this message
225:Learn how and when to remove this message
166:Learn how and when to remove this message
478:Alec D. Bangham MD FRS Achievement Award
142:by replacing them with more appropriate
493:
125:too closely associated with the subject
7:
582:Academic staff of Sichuan University
278:articles and as of 2017 carries an
14:
607:20th-century Taiwanese physicists
602:21st-century Taiwanese physicists
31:This article has multiple issues.
592:University of Pittsburgh faculty
577:Michigan State University alumni
294:
182:
123:may rely excessively on sources
112:
61:
20:
587:University of Tennessee faculty
533:North Carolina State University
260:UNC Eshelman School of Pharmacy
39:or discuss these issues on the
435:. His current work centers on
1:
455:targeted delivery system for
405:University of North Carolina
305:biography of a living person
401:Eshelman School of Pharmacy
325:must be removed immediately
623:
542:Controlled Release Society
70:This biographical article
419:. He has pioneered the
567:American biophysicists
417:targeted drug delivery
319:Please help by adding
272:Biomedical Engineering
314:references or sources
203:neutral point of view
83:by revising it to be
572:Taiwanese educators
562:20th-century births
429:polyethylene glycol
303:This section of a
397:
396:
389:
371:
253:
252:
245:
235:
234:
227:
176:
175:
168:
106:
105:
54:
614:
516:
515:
513:
512:
498:
392:
385:
381:
378:
372:
370:
329:
321:reliable sources
298:
297:
290:
262:and a Professor
248:
241:
230:
223:
219:
216:
210:
186:
185:
178:
171:
164:
160:
157:
151:
116:
108:
101:
98:
92:
65:
64:
57:
46:
24:
23:
16:
622:
621:
617:
616:
615:
613:
612:
611:
547:
546:
525:
520:
519:
510:
508:
500:
499:
495:
490:
393:
382:
376:
373:
330:
328:
318:
299:
295:
288:
249:
238:
237:
236:
231:
220:
214:
211:
200:
187:
183:
172:
161:
155:
152:
137:
117:
102:
96:
93:
81:help improve it
78:
66:
62:
25:
21:
12:
11:
5:
620:
618:
610:
609:
604:
599:
594:
589:
584:
579:
574:
569:
564:
559:
549:
548:
545:
544:
535:
524:
523:External links
521:
518:
517:
506:Google Scholar
492:
491:
489:
486:
425:clinical trial
395:
394:
302:
300:
293:
287:
284:
251:
250:
233:
232:
190:
188:
181:
174:
173:
120:
118:
111:
104:
103:
69:
67:
60:
55:
29:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
619:
608:
605:
603:
600:
598:
595:
593:
590:
588:
585:
583:
580:
578:
575:
573:
570:
568:
565:
563:
560:
558:
557:Living people
555:
554:
552:
543:
539:
536:
534:
530:
527:
526:
522:
507:
503:
497:
494:
487:
485:
483:
479:
474:
470:
466:
462:
458:
454:
450:
446:
442:
441:gene transfer
438:
434:
430:
426:
422:
418:
414:
410:
406:
402:
391:
388:
380:
369:
366:
362:
359:
355:
352:
348:
345:
341:
338: –
337:
333:
332:Find sources:
326:
322:
316:
315:
311:
306:
301:
292:
291:
285:
283:
281:
277:
276:peer reviewed
273:
269:
265:
261:
257:
247:
244:
229:
226:
218:
215:December 2023
208:
204:
198:
196:
195:autobiography
191:This article
189:
180:
179:
170:
167:
159:
149:
145:
141:
135:
131:
127:
126:
121:This article
119:
115:
110:
109:
100:
90:
86:
82:
76:
75:
74:like a résumé
68:
59:
58:
53:
51:
44:
43:
38:
37:
32:
27:
18:
17:
509:. Retrieved
502:"Leaf Huang"
496:
439:vectors for
437:nanoparticle
413:gene therapy
398:
383:
374:
364:
357:
350:
343:
336:"Leaf Huang"
331:
324:
307:
255:
254:
239:
221:
212:
192:
162:
153:
138:Please help
122:
94:
89:encyclopedic
71:
47:
40:
34:
33:Please help
30:
409:Chapel Hill
377:August 2023
156:August 2023
97:August 2023
72:is written
551:Categories
538:Leaf Huang
529:Leaf Huang
511:2017-10-31
488:References
347:newspapers
256:Leaf Huang
140:improve it
130:verifiable
36:improve it
433:liposomes
308:does not
286:Biography
207:talk page
144:citations
42:talk page
473:peptides
469:proteins
421:liposome
282:of 138.
268:NC State
361:scholar
310:include
280:h-index
134:neutral
85:neutral
79:Please
453:ligand
363:
356:
349:
342:
334:
270:joint
193:is an
465:siRNA
449:liver
445:tumor
368:JSTOR
354:books
471:and
461:mRNA
457:cDNA
447:and
415:and
340:news
312:any
132:and
87:and
540:on
531:on
443:in
407:at
264:UNC
146:to
553::
504:.
467:,
463:,
459:,
403:,
45:.
514:.
390:)
384:(
379:)
375:(
365:·
358:·
351:·
344:·
327:.
317:.
266:/
246:)
240:(
228:)
222:(
217:)
213:(
209:.
199:.
169:)
163:(
158:)
154:(
150:.
136:.
99:)
95:(
91:.
77:.
52:)
48:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
